← Back to Screener
Adlai Nortye Ltd. American Depositary Shares (ANL)
Price$12.03
Momentum ScoreA
Favorite Metrics
Price vs S&P 500 (26W)719.03%
Price vs S&P 500 (4W)-27.94%
VGM Score84.07
Market Capitalization$452.00M
All Metrics
Book Value / Share (Quarterly)$0.07
P/TBV (Annual)3.89x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.28
Price vs S&P 500 (YTD)729.91%
EPS (TTM)$-0.56
10-Day Avg Trading Volume0.15M
EPS Excl Extra (TTM)$-0.56
EPS (Annual)$-0.37
ROI (Annual)-98.40%
Cash / Share (Quarterly)$0.07
ROA (Last FY)-103.18%
EBITD / Share (TTM)$-0.36
Cash Flow / Share (Annual)$-0.28
P/B Ratio57.06x
P/B Ratio (Quarterly)6.85x
Net Income / Employee (Annual)$-325,900
Net Interest Coverage (TTM)-22.84x
ROA (TTM)-101.17%
EPS Incl Extra (Annual)$-0.37
Current Ratio (Annual)0.65x
Quick Ratio (Quarterly)0.60x
3-Month Avg Trading Volume0.59M
52-Week Price Return498.50%
Revenue / Employee (TTM)$45,900
Tangible BV / Share (Quarterly)$0.07
P/S Ratio (Annual)90.40x
Asset Turnover (Annual)0.15x
52-Week High$17.25
EPS Excl Extra (Annual)$-0.37
CapEx CAGR (5Y)-36.35%
26-Week Price Return734.97%
Quick Ratio (Annual)0.60x
13-Week Price Return29.92%
Total Debt / Equity (Annual)1.07x
Current Ratio (Quarterly)0.65x
Enterprise Value$470.32M
Revenue / Employee (Annual)$45,900
Pretax Margin (Annual)-710.56%
Cash / Share (Annual)$0.07
3-Month Return Std Dev127.91%
Net Income / Employee (TTM)$-494,200
ROE (Last FY)-203.53%
Net Interest Coverage (Annual)-24.50x
EPS Basic Excl Extra (Annual)$-0.37
P/FCF (TTM)23.76x
Total Debt / Equity (Quarterly)5.63x
EPS Incl Extra (TTM)$-0.56
ROI (TTM)-133.47%
Revenue / Share (Annual)$0.05
Tangible BV / Share (Annual)$0.23
Price vs S&P 500 (52W)470.29%
Year-to-Date Return740.85%
5-Day Price Return0.17%
EPS Normalized (Annual)$-0.37
ROA (5Y Avg)-76.78%
Net Profit Margin (Annual)-710.56%
Month-to-Date Return-16.33%
Cash Flow / Share (TTM)$-1.65
EBITD / Share (Annual)$-0.36
Operating Margin (Annual)-713.96%
EPS Basic Excl Extra (TTM)$-0.56
P/TBV (Quarterly)6.87x
P/B Ratio (Annual)3.89x
Book Value / Share (Annual)$0.23
Price vs S&P 500 (13W)20.18%
Beta1.24x
Revenue / Share (TTM)$0.05
ROE (TTM)-420.31%
52-Week Low$0.88
mGradeA
vgmGradeA
Show chart for
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
3.83
4.00
4.14
4.14
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ANLAdlai Nortye Ltd. American Depositary Shares | — | — | A | $12.03 |
| LLYEli Lilly & Co. | D | B | B | $1082.20 |
| JNJJohnson & Johnson | C | C | C | $223.51 |
| ABBVABBVIE INC. | D | C | C | $212.93 |
| MRKMerck & Co., Inc. | C | C | C | $115.17 |
| NVSNovartis AG | C | C | C | $145.68 |
| AZNAstraZeneca PLC | D | B | C | $179.71 |
| NVONovo-Nordisk A/S | B | B | C | $44.07 |
| ABTAbbott Laboratories | C | C | D | $87.78 |
| PFEPfizer Inc. | B | C | C | $25.63 |
| TEVATeva Pharmaceutical Industries Limited American Depositary Shares | C | C | C | $34.64 |
About
Adlai Nortye Ltd is a clinical-stage biotech company developing cancer therapies targeting multiple tumor types. The company's pipeline comprises three clinical-stage drug candidates and three preclinical assets.